Speqta Q3’21 Review: Awaiting the Revised Strategy - Redeye
Redeye leaves its Base Case unchanged for now, awaiting the revised strategy, following a Q3 report largely in line with our expectations. However, considering Speqta’s massive cash position, we raise our Bear Case.
ANNONS
Redeye leaves its Base Case unchanged for now, awaiting the revised strategy, following a Q3 report largely in line with our expectations. However, considering Speqta’s massive cash position, we raise our Bear Case.
